Cellular senescence is a state in which a cell stops dividing but stays metabolically active and can secrete signalling molecules that affect nearby tissue. In Unfair, senescence is treated as a research mechanism rather than a clinical target: it appears in some product stories, but it is not a proxy a user can track from home and it is not a proven longevity treatment.
Why "senolytic" claims need care
Some compounds, including fisetin and quercetin, are studied in research settings for their effect on senescent cells. Those studies are not the same as approved treatments, and the evidence tier for human longevity outcomes is low. A glossary entry on senescence should not be read as endorsement of any senolytic regimen.
When a label or article makes a senolytic promise for people, that claim usually outruns the data.
Where the term shows up in stacks
Senescence appears in mechanism notes attached to certain supplements and protocols. The pillar supplement stack mistakes to avoid is the relevant context, because senescence is a common source of stack mistakes: a strong story attached to a weak signal, often at doses far above what was studied.
A stack should not be redesigned around senescence claims. Senescence belongs in the mechanism of action column for an item, while the decision to keep or drop the item depends on tracked proxies.
Honest framing
The honest framing is that cellular senescence is a real biological state, that interest in it is reasonable, and that public-facing senolytic claims for humans remain ahead of the trial evidence. A self-experimentation app should not pretend otherwise.
How this appears in Unfair
In Unfair, senescence is a mechanism label on a small number of items. It does not change how a stack is reviewed. The review still uses proxies, adherence, and tolerance, not a story about clearing cells.
Clinical safety note
High-dose senolytic regimens taken from blog posts carry medication-interaction and tolerability questions that a glossary page cannot settle. A new symptom that follows a senescence-themed protocol is an adverse event, not evidence that the protocol is working.